ストックスクリーナーアプリを入手
11.57
4.80%
0.53
Vir Biotechnology Inc (VIR) 最新ニュース
BlackRock reports voting power over 20.6M shares in Vir Biotechnology (VIR). - Stock Titan
Vir Biotechnology (NASDAQ:VIR) Breaks Higher: Real Momentum? - Kalkine Media
Can Gilead's Deal With VIR Boost Its Oncology Pipeline and Growth? - Zacks Investment Research
Vir Biotechnology Sells 1.76 Million Shares to Gilead in $25M Stock Deal - Kalkine Media
VIR 8-K & SEC Filings - Yahoo! Finance Canada
Vir Biotechnology (VIR) Slides 4.25% to $10.82 as Support at $10.28 Comes Into FocusBPI Bear Confirmed - dars.gov.et
Vir Biotechnology (VIR) Slides 4.25% to $10.82 as Support at $10.28 Comes Into FocusSpring Pattern - dars.gov.et
Vir Biotechnology (VIR) Slides 4.25% to $10.82 as Support at $10.28 Comes Into FocusETF AUM Growth - https://www.siam.in/
Can Vir Biotechnology (NASDAQ:VIR) Keep Climbing After Latest Target Boost? - Kalkine Media
Aziz Sawaf, CFO of Vir Biotechnology (VIR), reports zero directly held common shares. - Stock Titan
One talk will cover hepatitis D response data through 96 weeks; another will study liver immune cells. - Stock Titan
A $150K sign-on bonus, contingent on continued employment, awaits Vir Biotechnology (VIR)'s incoming CFO. - Stock Titan
Vir Biotechnology, Inc. (NASDAQ:VIR) Stock Rated "Moderate Buy" by Sell-Side Brokerages - MarketBeat
Vir Biotechnology (NASDAQ:VIR) Nears Key Hepatitis Delta Readout - kalkinemedia.com
Vir Biotechnology (NasdaqGS:VIR) Stock Forecast & Analyst Predictions - Simply Wall Street
Vir Biotechnology Stock Price Forecast. Should You Buy VIR? - StockInvest.us
Engineers Gate Manager LP Sells 121,964 Shares of Vir Biotechnology, Inc. $VIR - MarketBeat
Former Vir (NASDAQ: VIR) officer sold $315K in stock, with more share sales planned - Stock Titan
WINTON GROUP Ltd Trims Stake in Vir Biotechnology, Inc. $VIR - MarketBeat
Vir Biotechnology (VIR) ex-officer to sell 28,333 shares from option exercise - Stock Titan
How (VIR) Movements Inform Risk Allocation Models - Stock Traders Daily
Legal & General Group Plc Invests $2.76 Million in Vir Biotechnology, Inc. $VIR - MarketBeat
Vir Biotechnology, Inc. (NASDAQ:VIR) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Bank of New York Mellon Corp Makes New $7.08 Million Investment in Vir Biotechnology, Inc. $VIR - MarketBeat
Vir Biotechnology stock gains on conference catalyst - ad-hoc-news.de
Man Group plc Takes $1.54 Million Position in Vir Biotechnology, Inc. $VIR - MarketBeat
Vir Biotechnology stock gains on new 52-week high and conference appearance - ad-hoc-news.de
Corient Private Wealth LP Invests $3.17 Million in Vir Biotechnology, Inc. $VIR - MarketBeat
Vir Biotechnology (NASDAQ:VIR) Sets New 52-Week HighShould You Buy? - MarketBeat
Vir Biotechnology stock gains on conference participation and 52-week high - ad-hoc-news.de
Vir Biotechnology stock hits 52-week high at 11.66 USD By Investing.com - Investing.com South Africa
Vir Biotechnology stock hits 52-week high at 11.66 USD By Investing.com - Investing.com Canada
Vir Biotechnology stock hits 52-week high at 11.66 USD By Investing.com - Investing.com India
Vir Biotechnology stock hits 52-week high at 11.66 USD By Investing.com - Investing.com Nigeria
Vir Biotechnology stock hits 52-week high at 11.66 USD - investing.com
Vir Biotechnology stock hits 52-week high at 11.66 USD By Investing.com - Investing.com UK
Vir Biotechnology (NASDAQ:VIR) Trading 4.8% HigherHere's What Happened - MarketBeat
Vir Biotechnology to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference - Business Wire
Vir Biotechnology CEO to speak at Morgan Stanley conference Sept. 14 - Stock Titan
Deutsche Bank AG Acquires Shares of 134,258 Vir Biotechnology, Inc. $VIR - MarketBeat
ARCH Venture Management LLC Invests $129.35 Million in Vir Biotechnology, Inc. $VIR - MarketBeat
Algert Global LLC Purchases 315,969 Shares of Vir Biotechnology, Inc. $VIR - MarketBeat
ADAR1 Capital Management LLC Acquires New Shares in Vir Biotechnology, Inc. $VIR - MarketBeat
Vir Biotechnology (NASDAQ: VIR) ex-officer lines up more sales - Stock Titan
Vir Biotechnology (NASDAQ:VIR) Shares Up 8.1%Time to Buy? - MarketBeat
Vir Biotechnology (NASDAQ: VIR) officer plans 14,352-share sale after 25K sale - Stock Titan
Vir Biotechnology (NASDAQ: VIR) ex-officer files notice for potential $245K stock sale - Stock Titan
Vir Biotechnology on Track for Record Winning Streak -- Data Talk - Bitget
Vir (VIR) Close and Levels: Adds 1.06% to Close at $9.49 in the Latest Reading; Key Levels: the $9.02 to $9.96 Range Remains in Focus in Latest TradingRevenue Weighted - vinanet.vn
The Bull Case For Vir Biotechnology (VIR) Could Change Following A Sudden Swing To Quarterly Profitability - Sahm
0.23%
1.80%
大文字化:
|
ボリューム (24 時間):